2020
DOI: 10.3390/cancers12123717
|View full text |Cite
|
Sign up to set email alerts
|

Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines

Abstract: We have determined the effects of the IGF-1R tyrosine kinase inhibitors BMS-754807 (BMS) and OSI-906 (OSI) on cell proliferation and cell-cycle phase distribution in human colon, pancreatic carcinoma, and glioblastoma cell lines and primary cultures. IGF-1R signaling was blocked by BMS and OSI at equivalent doses, although both inhibitors exhibited differential antiproliferative effects. In all pancreatic carcinoma cell lines tested, BMS exerted a strong antiproliferative effect, whereas OSI had a minimal effe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 52 publications
(89 reference statements)
1
10
0
Order By: Relevance
“…A previous study has indicated that linsitinib (OSI-906, an IGF-1 receptor inhibitor) can reduce the expression of C/EBPα, C/EBPβ, PPARγ and adiponectin (67). In the present study, treatment with DAPT increased the expression levels of IGF-1 in HemSCs.…”
Section: Discussionsupporting
confidence: 66%
“…A previous study has indicated that linsitinib (OSI-906, an IGF-1 receptor inhibitor) can reduce the expression of C/EBPα, C/EBPβ, PPARγ and adiponectin (67). In the present study, treatment with DAPT increased the expression levels of IGF-1 in HemSCs.…”
Section: Discussionsupporting
confidence: 66%
“…IGF-1R is a plasma membrane receptor with tyrosine kinase activity, whose inhibitors have been used to treat carcinoma cell lines, with a strong non-proliferative effect ( Fuentes-Baile et al, 2020 ). The IGF-1R elevated expression has also been associated with inhibition of apoptosis and increased proliferation rate and angiogenesis in patients with cancer ( Matsubara et al, 2009 ; Valsecchi et al, 2012 ).…”
Section: Discussionmentioning
confidence: 99%
“…IGF1R depletion/inhibition sensitizes CRC cells to radiotherapy (converting them to radiosensitive), as shown in HT-29 and SW480 cell lines where IGF1R was inhibited by NVP-ADW742 [ 213 ] and in HT-29, SW480 and DLD-1 cells pretreated with BMS-754807 [ 214 ]. The inhibitory effect of BMS-754807 on colon cancer cell growth was stronger compared to the effect of linsitinib, and the anti-neoplastic effect was mostly independent of IGF1R [ 215 ]. A prolonged treatment of colon cancer cells with BMS-754807 and GSK1838705A (inhibitors of IGF1R and IR) leads to cell survival, due to the activation of ribosomal protein S6 kinase 1 [ 216 ].…”
Section: Therapeutic Potential Of the Insulin-like Growth Factor Sign...mentioning
confidence: 99%